The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.